CYRX vs TECH · rev $228.4M vs P/E 65, rev $1.22B
Cryoport Inc (CYRX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Cryoport Inc (CYRX) is a integrated freight & logistics company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported CYRX revenue for 2024-12-31 was $228.4M. Net income was -$114.8M. Revenue was down 2.1% from 2023-12-31 to 2024-12-31. CYRX currently screens at market cap $365.5M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
CYRX currently screens at market cap $365.5M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the CYRX and TECH stock pages for the full models.
Not investment advice.